UBS O'Connor »

X4 Pharmaceuticals shares owned by UBS O'Connor

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2025-06-30 $152k 80k 1.90

More positions owned by UBS O'Connor

Verona Pha Spons (VRNA)
Mr Cooper Group
NVIDIA Corporation (NVDA)
Snowflake Note1 (Principal)
Spirit Aer Comcl (SPR)
Peloton In Note2 (Principal)
Halozyme T Note0 (Principal)
Alliant Energy Corporation (LNT)
Draftkings Note3 (Principal)
Southern C Note4 (Principal)
Entergy Corporation (ETR)
Southern Company (SO)
Packaging Corporation of America (PKG)
Duke Energ Note4 (Principal)
American W Note3 (Principal)

View all positions for UBS O'Connor

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
BVF
Nantahala Capital Management
Rosalind Advisors
Deep Track Capital
Stonepine Capital Management
Kingdon Capital Management
Stempoint Capital
Vanguard Group
Boothbay Fund Management
Pale Fire Capital SE
UBS Group
Susquehanna International
Palumbo Wealth Management
Geode Capital Management

View all funds holding X4 Pharmaceuticals